U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H10N2S
Molecular Weight 202.276
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 6-PHENYL-2,3-DIHYDROIMIDAZO(2,1-B)THIAZOLE

SMILES

C1CN2C=C(N=C2S1)C3=CC=CC=C3

InChI

InChIKey=ZUSMDKHVRFBRNJ-UHFFFAOYSA-N
InChI=1S/C11H10N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,8H,6-7H2

HIDE SMILES / InChI

Molecular Formula C11H10N2S
Molecular Weight 202.276
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 09:59:53 GMT 2023
Edited
by admin
on Sat Dec 16 09:59:53 GMT 2023
Record UNII
KEA4JRD166
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
6-PHENYL-2,3-DIHYDROIMIDAZO(2,1-B)THIAZOLE
Systematic Name English
LEVAMISOLE HYDROCHLORIDE IMPURITY D [EP IMPURITY]
Common Name English
LEVAMISOLE FOR VETERINARY USE IMPURITY D [EP IMPURITY]
Common Name English
6-PHENYL-2,3-DIHYDROIMIDAZO(2,1-B)(1,3)THIAZOLE [WHO-IP]
Common Name English
IMIDAZO(2,1-B)THIAZOLE, 2,3-DIHYDRO-6-PHENYL-
Systematic Name English
LEVAMISOLE HYDROCHLORIDE IMPURITY D [WHO-IP]
Common Name English
Code System Code Type Description
CAS
4335-28-8
Created by admin on Sat Dec 16 09:59:53 GMT 2023 , Edited by admin on Sat Dec 16 09:59:53 GMT 2023
PRIMARY
FDA UNII
KEA4JRD166
Created by admin on Sat Dec 16 09:59:53 GMT 2023 , Edited by admin on Sat Dec 16 09:59:53 GMT 2023
PRIMARY
PUBCHEM
432820
Created by admin on Sat Dec 16 09:59:53 GMT 2023 , Edited by admin on Sat Dec 16 09:59:53 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
- for veterinary use - correction factor: for the calculation of content, multiply the peak area of impurity D by 1.3
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
The chromatogram obtained with solution (1) may show peaks due to the following impurities eluting at the following relative retention with reference to levamisole (retention time about 3.5 minutes): impurity D about 1.6. In the chromatogram obtained with solution (1): the area of any peak corresponding to impurity D, when multiplied by a correction factor of 1.3, is not greater than 2 times the area of the peak due to levamisole in the chromatogram obtained with solution (4) (0.2%).
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP